Gevo, which makes biobased alternatives to petroleum-based chemicals and fuels, will see its quiet period end on Sunday, March 20. On February 8, the company raised $107 million by offering 7.15 million shares at $15, at high end of the range of $13 to $15. UBS Investment Bank, Piper Jaffray and Citi acted as lead managers on the deal.
